ArticleBMC geriatrics2025
Trends of the burden, risk factors, and future projections of peripheral artery disease in the elderly.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Epidemiology of cardiovascular disease and diabetes in 2026: expanding prevalence, escalating costs, and the limits of contemporary prevention.Cardiovascular diabetology. Endocrinology reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundElderly individuals have a higher burden of peripheral arterial disease (PAD), but currently, there are no global reports on the disease burden of PAD in patients aged 60 and above.
methodsThis study analyzed data on elderly patients with PAD from 1990 to 2021 using the Global Burden of Disease (GBD) database, focusing on prevalence, mortality, and Disability-Adjusted Life Years (DALYs). We summarized the trends in disease burden across 21 GBD regions and 204 countries and projected the global burden for the next 20 years.
resultsBetween 1990 and 2021, the prevalence cases of elderly PAD individuals worldwide increased by 105%, from 42,618,313 to 87,523,486. However, the Age-standardized prevalence rate (ASPR) decreased to 8,220.2 cases per 100,000 population (95% UI: 6,717.3-9,995.7), with an Estimated Annual Percentage Change (EAPC) of -0.52 (95% CI: -0.56 to -0.48). Similar trends were observed in mortality and DALYs. In 2021, elderly individuals represented 77% of PAD prevalence cases and 94% of related mortality cases. The ASPR for women was 1.7 times higher than for men, yet women experienced a lower mortality rate and DALY rate, suggesting a heavier overall disease burden. The disease burden increased with the Socio-Demographic Index (SDI), with the fastest growth observed in Low and Low-middle SDI regions. Among the GBD regions, High-Income North America and Western Europe had the highest burden, with the United States bearing the heaviest burden of all 204 countries. High fasting blood glucose was the leading risk factor, contributing 36% of the PAD burden, with population growth being the primary driver of the rising burden. The disease burden is projected to intensify over the next two decades.
conclusionsFrom 1990 to 2021, the burden of PAD in the elderly has steadily increased, with projections for continued growth over the next two decades. Addressing diabetes and global population trends is essential for guiding effective public health strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.